We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$63.8B
AUM Growth
+$3.93B
(+6.6%)
Cap. Flow
-$1.01B
Cap. Flow
% of AUM
-1.58%
Top 10 Holdings %
Top 10 Hldgs %
22.75%
Holding
3,125
New
60
Increased
388
Reduced
2,521
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$20M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$11.8M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$11.8M |
| 4 |
Caesars Entertainment
CZR
|
+$11.1M |
| 5 |
PROG Holdings
PRG
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$59.2M |
| 2 |
PPLI
People Inc
PPLI
|
+$24.6M |
| 3 |
CZR
Caesars Entertainment Corporation
CZR
|
+$19.1M |
| 4 |
Teradyne
TER
|
+$16.1M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$15.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.2% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 11.87% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Intrepid Potash
IPI
$469M
| $122K | ﹤0.01% |
14,414
-2,554
| -15% | -$24.3K |
|
|
UBFO
2827
DELISTED
United Security Bancshares
UBFO
| $122K | ﹤0.01% |
19,948
-2,865
| -13% | -$18K |
|
2828
X4 Pharmaceuticals
XFOR
$460M
| $122K | ﹤0.01% |
600
-52
| -8% | -$12.5K |
|
|
PVLA
2829
Palvella Therapeutics
PVLA
$2.27B
| $122K | ﹤0.01% |
736
-108
| -13% | -$24.6K |
|
|
PZN
2830
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $122K | ﹤0.01% |
22,741
-2,970
| -12% | -$15.5K |
|
2831
DHI Group
DHX
$173M
| $121K | ﹤0.01% |
53,487
-11,336
| -17% | -$28.1K |
|
|
OPTN
2832
DELISTED
OptiNose
OPTN
| $121K | ﹤0.01% |
2,070
-293
| -12% | -$21.7K |
|
2833
Universal Technical Institute
UTI
$1.59B
| $120K | ﹤0.01% |
23,713
-5,999
| -20% | -$42.2K |
|
|
CURO
2834
DELISTED
CURO Group Holdings Corp.
CURO
| $120K | ﹤0.01% |
17,019
-3,140
| -16% | -$23.9K |
|
2835
Stereotaxis
STXS
$141M
| $119K | ﹤0.01% |
33,169
-7,660
| -19% | -$29.5K |
|
|
IVAC
2836
DELISTED
Intevac Inc
IVAC
| $119K | ﹤0.01% |
21,660
-4,710
| -18% | -$27.2K |
|
|
NBSE
2837
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $117K | ﹤0.01% |
768
-22
| -3% | -$3.59K |
|
|
AGTC
2838
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $114K | ﹤0.01% |
23,430
-4,895
| -17% | -$26.7K |
|
|
MR
2839
DELISTED
Montage Resources Corporation Common Stock
MR
| $114K | ﹤0.01% |
25,947
-4,148
| -14% | -$19.2K |
|
2840
Fennec Pharmaceuticals
FENC
$402M
| $112K | ﹤0.01% |
18,422
-506
| -3% | -$3.57K |
|
|
FNHC
2841
DELISTED
FedNat Holding Company Common Stock
FNHC
| $112K | ﹤0.01% |
17,708
-2,766
| -14% | -$25K |
|
|
LUNA
2842
DELISTED
Luna Innovations Incorporated
LUNA
| $112K | ﹤0.01% |
18,693
-4,995
| -21% | -$29.6K |
|
2843
BGSF Inc
BGSF
$60M
| $111K | ﹤0.01% |
13,125
-1,337
| -9% | -$12.9K |
|
2844
Vitamin Cottage Natural Grocers
NGVC
$654M
| $110K | ﹤0.01% |
11,121
-14,635
| -57% | -$191K |
|
2845
Harvard Bioscience
HBIO
$29.2M
| $109K | ﹤0.01% |
3,627
-805
| -18% | -$27.1K |
|
2846
Dyadic International
DYAI
$36.4M
| $108K | ﹤0.01% |
14,232
-2,760
| -16% | -$22.8K |
|
2847
Information Services Group
III
$251M
| $107K | ﹤0.01% |
50,689
-7,452
| -13% | -$15.8K |
|
|
STR
2848
DELISTED
Sitio Royalties
STR
| $107K | ﹤0.01% |
10,965
-1,786
| -14% | -$20.1K |
|
2849
Arq
ARQ
$89.3M
| $106K | ﹤0.01% |
26,054
-3,370
| -11% | -$14.4K |
|
2850
Asure Software
ASUR
$250M
| $105K | ﹤0.01% |
13,852
-2,835
| -17% | -$19.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2020 Portfolio in Review
As of Q3 2020, RhumbLine Advisers held 3,125 positions worth $63.8B, up 6.6% from $59.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
RhumbLine Advisers's Q3 2020 filing shows 60 new, 388 increased, 2,521 reduced and 139 closed positions. Its largest new stake was PROG Holdings: 245,531 shares worth $11.8M. The largest sale was Apple, an estimated $59.2M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2020 buy was PROG Holdings: 245,531 shares worth $11.8M.
- RhumbLine Advisers added most to Match Group in Q3 2020, an estimated $20M increase.
- RhumbLine Advisers's biggest Q3 2020 reduction was Apple, cutting an estimated $59.2M.
- RhumbLine Advisers fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $19.1M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $63.8B portfolio in Q3 2020.
- RhumbLine Advisers opened 60 new positions and closed 139 in Q3 2020.
- RhumbLine Advisers's portfolio value rose 6.6% quarter-over-quarter to $63.8B.
Based on RhumbLine Advisers's 13F filing for Q3 2020, filed 12 Nov 2020.